MiR-148b functions as a tumor suppressor in pancreatic cancer by targeting AMPKα1

Molecular Cancer Therapeutics

Volumn 12, Issue 1, 2013, Pages 83-93

  Zhao, Gang ^a   Zhang, Jun Gang ^a   Liu, Yang ^a   Qin, Qi ^a   Wang, Bo ^a   Tian, Kui ^a   Liu, Lin ^a   Li, Xiang ^a   Niu, Yi ^a   Deng, Shi Chang ^a   Wang, Chun You ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; AMP KINASE ALPHA 1; ANTINEOPLASTIC AGENT; MICRORNA; MICRORNA 148B; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CANCER PROGNOSIS; CANCER TISSUE; CARCINOGENICITY; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL PROLIFERATION; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MALE; MOUSE; NONHUMAN; PANCREAS CANCER; PRIORITY JOURNAL; RNA INTERFERENCE; TUMOR VOLUME;

ADULT; AGED; AMP-ACTIVATED PROTEIN KINASES; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; FEMALE; FLUOROURACIL; GENE EXPRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, TUMOR SUPPRESSOR; HUMANS; INHIBITORY CONCENTRATION 50; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84872586016     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: 10.1158/1535-7163.MCT-12-0534-T     Document Type: Article

References (41)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
2. Croce CM, Calin GA. miRNAs, cancer, and stem cell division. Cell 2005;122:6-7.
3. Gregory RI, Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005;65:3509-12.
4. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, et al. MicroRNA expression profiles classify human cancers. Nature 2005;435:834-8.
5. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006;103:2257-61.
6. Lujambio A, Calin GA, Villanueva A, Ropero S, Sánchez- Céspedes M, Blanco D, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008;105: 13556-61.
7. Steele CW, Oien KA, McKay CJ, Jamieson NB. Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. Pancreas 2011;40: 1165-71.
8. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics, 2007. CA Cancer J Clin 2007;57:43-66.
9. Niedergethmann M, Alves F, Neff JK, Heidrich B, Aramin N, Li L, et al. Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer 2007;97:1432-40.
10. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer 2002;2:897-909.
11. Lomberk GA. Epigenetic silencing of tumor suppressor genes in pancreatic cancer. J Gastrointest Cancer 2011;42:93-9.
12. Chang H, Zhou X, Wang ZN, Song YX, Zhao F, Gao P, et al. Increased expression of miR-148b in ovarian carcinoma and its clinical significance. Mol Med Report 2012;5:1277-80.
13. Nymark P, Guled M, Borze I, Faisal A, Lahti L, Salmenkivi K, et al. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer. Genes Chromosomes Cancer 2011;50:585-97
14. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, et al. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007;297:1901-8.
15. Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, et al. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007;26:4442-52.
16. Song YX, Yue ZY, Wang ZN, Xu YY, Luo Y, Xu HM, et al. MicroRNA- 148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol Cancer 2011; 10:1.
17. Song Y, Xu Y, Wang Z, Chen Y, Yue Z, Gao P, et al. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer. Int J Cancer 2012;131:1042-51.
18. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev 2011;25:1895-908.
19. Cantó C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, et al.AMPKregulates energy expenditure by modulatingNAD+ metabolism and SIRT1 activity. Nature 2009;458:1056-60.
20. Hardie DG, Carling D. The AMP-activated protein kinase. Fuel gauge of the mammalian cell? Eur J Biochem 1997;246:259-273.
21. Woodard J, Joshi S, Viollet B, Hay N, Platanias LC. AMPK as a therapeutic target in renal cell carcinoma. Cancer Biol Ther 2010;10: 1168-77.
22. Chen MB, Shen WX, Yang Y,WuXY, Gu JH, Lu PH. Activation of AMPactivated protein kinase is involved in vincristine-induced cell apoptosis in B16 melanoma cell. J Cell Physiol 2011;226:1915-25.
23. Kim EK, Park JM, Lim S, Choi JW, Kim HS, Seok H, et al. Activation of AMP-activated protein kinase is essential for lysophosphatidic acidinduced cell migration in ovarian cancer cells. J Biol Chem 2011;286: 24036-45.
24. Lee YK, Park SY, Kim YM, Kim DC, Lee WS, Surh YJ, et al. Suppression of mTOR via Akt-dependent and -independent mechanisms in selenium- treated colon cancer cells: involvement of AMPKalpha1. Carcinogenesis 2010;31:1092-9.
25. Chiu YC, Shieh DC, Tong KM, Chen CP, Huang KC, Chen PC, et al. Involvement of AdipoR receptor in adiponectin-induced motility and alpha2beta1 integrin upregulation in human chondrosarcoma cells. Carcinogenesis 2009;30:1651-9.
26. Kato K, Ogura T, Kishimoto A, Minegishi Y, Nakajima N, Miyazaki M, et al. Critical roles of AMP-activated protein kinase in constitutive tolerance of cancer cells to nutrient deprivation and tumor formation. Oncogene 2002;21:6082-90.
27. Zhao G, Cui J, Zhang JG, Qin Q, Chen Q, Yin T, et al. SIRT1 RNAi knockdown induces apoptosis and senescence, inhibits invasion and enhances chemosensitivity in pancreatic cancer cells. Gene Ther 2011;18:920-8.
28. Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH, Park HS, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Clin Cancer Res 2009;15:4453-9.
29. Swinnen JV, Beckers A, Brusselmans K, Organe S, Segers J, Timmermans L, et al. Mimicry of a cellular low energy status blocks tumor cell anabolism and suppresses the malignant phenotype. Cancer Res 2005;65:2441-8.
30. Hong YB, Kang HJ, Kim HJ, Rosen EM, Dakshanamurthy S, Rondanin R, et al. Inhibition of cell proliferation by a resveratrol analog in human pancreatic and breast cancer cells. Exp Mol Med 2009;41: 151-60.
31. Scalera F, Fulge B, Martens-Lobenhoffer J, Heimburg A, Bode-Böger SM. Red wine decreases asymmetric dimethylarginine via SIRT1 induction in human endothelial cells. Biochem Biophys Res Commun 2009;390:703-9.
32. Zhang J, Yang Y, Yang T, Liu Y, Li A, Fu S, et al. microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br J Cancer 2010;103:1215-20.
33. Zhang C, Wang C, Chen X, Yang C, Li K, Wang J, et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin Chem 2010;56:1871-9.
34. Jaffee EM, Hruban RH, Canto M, Kern SE. Focus on pancreas cancer. Cancer Cell 2002;2:25-8.
35. Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363:1049-57.
36. Luo Z, Zang M, Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol 2010;6:457-70.
37. Hashimoto K, Kato K, Imamura K, Kishimoto A, Yoshikawa H, Taketani Y, et al. 5-Amino-4-imidazolecarboxamide riboside confers strong tolerance to glucose starvation in a 50-AMP-activated protein kinase-dependent fashion. Biochem Biophys Res Commun 2002;290: 263-7.
38. Pandolfi PP. Aberrant mRNA translation in cancer pathogenesis: an old concept revisited comes finally of age. Oncogene 2004;23: 3134-7.
39. Hardie DG. The AMP-activated protein kinase pathway - new players upstream and downstream. J Cell Science 2004;117: 5479-87.
40. Lee YK, Lee WS, Kim GS, Park OJ. Anthocyanins are novel AMPKa1 stimulators that suppress tumor growth by inhibiting mTOR phosphorylation. Oncol Rep 2010;24:1471-7.
41. Tang CH, Lu ME. Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways. Prostate 2009;69:1781-9.